biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > False starts?

<< Previous

Bullboard Posts

Next >>

Post by ronrydellon Sep 08, 2022 11:16am

202 Views

Post# 34949420

False starts?

We suddenly get some nice volume and increased share prices....but...then it stops as suddenly as it rose! One is led to believe that we might FINALLY get some long awaited news.....This is the problem with Bioasis.....very little encouraging followthru.....perhaps if the CEO went back to full time she could rethink this strategy of such sparce communication with the poor unserved shareholders? Comments?

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading